MFN2 and Alzheimer disease: Mfn2 contributes to mitochondrial fusion, and the mRNA and protein levels of Mfn2 in the hippocampus of AD mice decreased compared with those of the control group (P < 0.05), whereas EA treatment significantly increased its mRNA and protein levels (Figures 2(b)–2(d)).